Author

Yvonne H. C. M. Smolders

Observed names: Smolders, Yvonne H C M, Y. Smolders, Yvonne H C M Smolders, Yvonne H. C. Smolders, Yvonne H. Smolders, Yvonne H.C.M. Smolders

Institutions: Radboud University Nijmegen, Radboud University Medical Center

Observed institutions: Memorial Sloan Kettering Cancer Center, Radboud University Nijmegen, Utrecht University, Radboud University Medical Center, University Medical Center Utrecht

OpenAlex ID: A5000683672

Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle

2014 · L. De Mattos-Arruda, B. Weigelt, et al. · Annals of Oncology · 386

HIF-1α Overexpression in Ductal Carcinoma In Situ of the Breast in BRCA1 and BRCA2 Mutation Carriers

2013 · Petra van der Groep, Paul J. van Diest, et al. · PLoS ONE · 34

Corrections to “Capturing intra-tumor genetic heterogeneity byde novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle”

2018 · L De Mattos-Arruda, B. Weigelt, et al. · Annals of Oncology · 27

Distinct claudin expression characterizes BRCA 1‐related breast cancer

2014 · Marise R Heerma van Voss, Paul J van Diest, et al. · Histopathology · 21

Secretome proteomics reveals candidate non-invasive biomarkers of BRCA1 deficiency in breast cancer

2016 · Marc Warmoes, Siu W. Lam, et al. · Oncotarget · 15

Optimizing the detection of hereditary predisposition in women with epithelial ovarian cancer: nationwide implementation of the Tumor-First workflow

2024 · Vera M. Witjes, Dorien M. A. Hermkens, et al. · Familial Cancer · 6

Healthcare professionals’ perspectives on implementation of universal tumor DNA testing in ovarian cancer patients: multidisciplinary focus groups

2022 · Vera M. Witjes, Jozé C. C. Braspenning, et al. · Familial Cancer · 5

Comprehensive Proteomic Profiling–derived Immunohistochemistry-based Prediction Models for BRCA1 and BRCA2 Germline Mutation-related Breast Carcinomas

2018 · Shoko Vos, Sjoerd G. Elias, et al. · The American Journal of Surgical Pathology · 4

Nationwide implementation and evaluation of the Tumor‐First workflow for genetic testing in ovarian carcinoma

2025 · Vera M. Witjes, Joanne A. de Hullu, et al. · International Journal of Cancer · 3

The claudin expression signature of BRCA1-deficient breast cancer.

2013 · Marise R. Heerma van Voss, Petra van der Groep, et al. · Journal of Clinical Oncology

Works count: 12

Citation count: 503

H-index: 6

I10-index: 5